In the same study, KRAS mutant and dependent pancreatic cancer lines also exhibited over 8,000 differential methylations of CpGs upon KRAS knockdown and differentially methylated promoters also showed an enrichment of genes involved in differentiation and development (Tew et al., 2020). This evidence concerns the gene KRAS and familial pancreatic carcinoma.